NGS is evolving: collaboration and tech lead the way
Drug Target Review
JULY 15, 2025
billion by 2029, a compound annual growth rate (CAGR) of approximately 13.2 The latest technologies are empowering researchers with faster, more efficient and more accessible genomic tools, leading to richer data generation and accelerating progress in areas like cancer genomics, rare disease research and infectious disease surveillance.
Let's personalize your content